Skip to main content

Table 2 Characteristics of individuals with and without an ANA-related autoimmune disease

From: Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease

Characteristics

With AD

(n = 20,497)

ANA + 

(n = 10, 931)

ANA-

(n = 9,566)

Without AD

(n = 49,546)

ANA + 

(n = 15,648)

ANA-

(n = 33,898)

Female (%)

15,733 (76.8%)

9,167 (83.9%)

6566 (68.6%)

32,612 (65.3%)

11,588 (74.1%)

20,730 (61.2%)

White race (%)a

15,957 (77.9%)

8,305 (76.0%)

7652 (80.0%)

36,518 (73.7%)

11,552 (73.8%)

24,966 (73.7%)

Year of birth

1962 [1951, 1975]

1962 [1950, 1976]

1961 [1951, 1975]

1963 [1951, 1978]

1962 [1950, 1976]

1964 [1952, 1978]

Age at testing (years)

49.4 [36.2, 60.2]

49.5 [35.7, 60.7]

49.2 [36.7, 59.5]

47.9 [33.8, 59.5]

50.2 [35.9, 61.8]

46.9 [32.9, 58.3]

Length of FU (years)

8.7 [3.4, 14.1]

8.6 [3.2, 13.9]

8.9 [3.6, 14.4]

6.4 [1.3, 12.6]

6.2 [1.1, 12.4]

6.4 [1.4, 12.7]

  1. ANA Antinuclear antibodies, ANA + ANA positive, ANA- ANA negative, AD Autoimmune disease, FU Follow-up
  2. aRace recorded as white in the electronic heath record (EHR). Data is shows as counts (percentage) for categorical variables and median [interquartile range] for continuous variables